It’s no secret: Big Pharma faces big challenges. The industry could lose tens of billions in sales to generics over the next five years as patented drugs lose protected status. Pharmaceutical firms are fighting back by pumping record dollars into R&D, yet companies only won FDA approval last year for 21 new drugs. To increase their odds of success, global Pharma giants are looking for ever-better ways to revitalize their pipelines by developing novel and innovative programs, partnerships, and approaches to fostering innovation. As the world’s leading center of life sciences innovation, Boston is the hub of much of this activity. This forum will bring together pharmaceutical industry leaders, biotech executives, and startup entrepreneurs to highlight what’s happening on the front lines of innovation.
Deborah Dunsire, CEO, Millennium: The Takeda Oncology Company
Christoph Westphal, CEO, Sirtris, SVP, Centre of Excellence for External Drug Discovery, GlaxoSmithKline
Featured speakers and panelists include:
Noubar Afeyan, Co-founder, Managing Partner and CEO, Flagship Ventures
Michelle Dipp, Head of US CEEDD, GlaxoSmithKline
Maggie Flanagan LeFlore, Managing Director, MedImmune Ventures
Jean George, General Partner, Advanced Technology Ventures
Tuan Ha-Ngoc, President and CEO, Aveo Pharmaceuticals
Russell Herndon, President and CEO, Hydra Biosciences
Campbell Murray, Managing Director, Novartis Venture Funds
Natarajan Sethuraman, Senior Director, GlycoFi Site Head, Merck & Company
David Steinberg, Founding CEO, Enlight Biosciences
Joseph Yanchik III, President and CEO, Aileron Therapeutics
Daphne Zohar, Founder and Managing Partner, PureTech Ventures
Registration: 1:15 – 2:00 pm
Program: 2:00 – 5:15 pm
Networking reception: 5:15 pm – 6:30 pm
Early Bird Registration (ends October 21): $175
Regular Registration: $295
On-Site Registration: $350
Student Registration: $50
Student scholarships available through the Stay in MA program.
To inquire about press registration, e-mail email@example.com.
Tickets are transferable but not refundable.